Karl Kieburtz, MD, MPH

Professor of Neurology and Community and Preventive Medicine
University of Rochester Medical Center

Karl Kieburtz obtained his BA in Neuroscience from Amherst College. He completed his MD and MPH degrees at the University of Rochester, as well as his Neurology residency and a fellowship in Experimental Therapeutics. He is currently a Professor (part time) in the Department of Neurology, as well as a Managing Principal and Co-founder of Clintrex Research, a BlueRidge Life Sciences company. He previously served as the Director of the Clinical & Translational Research Institute and the Director of the Center for Human Experimental Therapeutics at the University of Rochester. In addition, he was the chair of the Parkinson Study Group (PSG) Executive Committee and the Chair of the Steering Committee for the NIH Exploratory Trials in PD (NET-PD). Both programs, fostered multi-institutional academic research and coordinated multi-center trials examining the symptomatic and neuroprotective effects of experimental interventions for neurodegenerative diseases.

Dr. Kieburtz's research interests focus on treating neurodegenerative diseases, particularly Parkinson's disease and Huntington's disease. He is also interested in trials of potential neuroprotective agents for the treatment of other neurodegenerative diseases. He had NIH funding as a principal investigator or co-principal investigator for multi-center trials in PD, HD, and HIV-related neurological disorders for over 2 decades.

Dr. Kieburtz was chair of the FDA Peripheral and Central Nervous System Drugs Advisory Committee, an officer of the American Neurological Association (ANA), and Associate Editor of the Movement Disorders and Neurology journals.